Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy.

Abstract:

:Uniformly adopted response criteria are essential for assessment of therapies incorporating conventional chemotherapy and chemoimmunotherapy regimens. Recently, immunomodulatory agents, such as immune checkpoint inhibitors, have demonstrated impressive activity in a broad range of lymphoma histologies. However, these agents may be associated with clinical and imaging findings during treatment suggestive of progressive disease (PD) despite evidence of clinical benefit (eg, tumor flare or pseudo-progression). Considering this finding as PD could lead to patients being prematurely removed from a treatment from which they actually stand to benefit. This phenomenon has been well described with checkpoint blockade therapy in solid tumors and anecdotally seen in lymphoma as well. To address this issue in the context of lymphoma immunomodulatory therapy, a workshop was convened to provide provisional recommendations to modify current response criteria in patients receiving these and future agents in clinical trials. The term "indeterminate response" was introduced to identify such lesions until confirmed as flare/pseudo-progression or true PD by either biopsy or subsequent imaging.

journal_name

Blood

journal_title

Blood

authors

Cheson BD,Ansell S,Schwartz L,Gordon LI,Advani R,Jacene HA,Hoos A,Barrington SF,Armand P

doi

10.1182/blood-2016-05-718528

subject

Has Abstract

pub_date

2016-11-24 00:00:00

pages

2489-2496

issue

21

eissn

0006-4971

issn

1528-0020

pii

blood-2016-05-718528

journal_volume

128

pub_type

杂志文章,评审

相关文献

BLOOD文献大全
  • Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells.

    abstract::Tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 are proteins with proteinase-inhibiting and cytokine properties. TIMP-1 is active primarily in B cells and B-cell lymphomas, whereas TIMP-2 expression is restricted to T cells. The expression of TIMP-1 and TIMP-2 in lymph nodes from patients with Hodgkin disea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.1.258

    authors: Oelmann E,Herbst H,Zühlsdorf M,Albrecht O,Nolte A,Schmitmann C,Manzke O,Diehl V,Stein H,Berdel WE

    更新日期:2002-01-01 00:00:00

  • Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures.

    abstract::To characterize juvenile chronic myelogenous leukemia (JCML), the proliferative properties of bone marrow (BM) and peripheral blood (PB) cells from nine patients were studied using assays for CFU-C and CFU-GEMM and liquid cultures. All specimens showed two reproducible abnormalities: impaired growth of normal hematopo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Estrov Z,Grunberger T,Chan HS,Freedman MH

    更新日期:1986-05-01 00:00:00

  • Role of ADP receptors on platelets in the growth of ovarian cancer.

    abstract::We investigated the effect of platelets on ovarian cancer and the role of adenosine diphosphate (ADP) receptors (P2Y12 and P2Y1) on platelets in the growth of primary ovarian cancer tumors. We showed that in murine models of ovarian cancer, a P2Y12 inhibitor (ticagrelor) reduced tumor growth by 60% compared with aspir...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-02-769893

    authors: Cho MS,Noh K,Haemmerle M,Li D,Park H,Hu Q,Hisamatsu T,Mitamura T,Mak SLC,Kunapuli S,Ma Q,Sood AK,Afshar-Kharghan V

    更新日期:2017-09-07 00:00:00

  • Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial.

    abstract::Leukemia relapse is a major cause of treatment failure for patients with acute leukemia given allogeneic bone marrow transplantation (BMT). This study evaluated whether a reduction of the dosage of cyclosporine-A (Cs-A) used for graft versus host disease (GVHD) prophylaxis could reduce relapse rate (RR) in children wi...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Locatelli F,Zecca M,Rondelli R,Bonetti F,Dini G,Prete A,Messina C,Uderzo C,Ripaldi M,Porta F,Giorgiani G,Giraldi E,Pession A

    更新日期:2000-03-01 00:00:00

  • A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.

    abstract::Tissue-derived adenosine, acting via the adenosine A(2A) receptor (A(2A)R), is emerging as an important negative regulator of T-cell function. In this report, we demonstrate that A(2A)R stimulation not only inhibits the generation of adaptive effector T cells but also promotes the induction of adaptive regulatory T ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-081646

    authors: Zarek PE,Huang CT,Lutz ER,Kowalski J,Horton MR,Linden J,Drake CG,Powell JD

    更新日期:2008-01-01 00:00:00

  • Mutual inhibition of murine erythropoiesis and granulopoiesis during combined erythropoietin, granulocyte colony-stimulating factor, and stem cell factor administration: in vivo interactions and dose-response surfaces.

    abstract::We investigated the in vivo effects of erythropoietin (EPO) on granulopoiesis and, conversely, the effect of granulocyte colony-stimulating factor (G-CSF) treatment on erythropoiesis. Recombinant human EPO at four different doses in combination with recombinant human G-CSF also at four different doses was simultaneous...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: de Haan G,Engel C,Dontje B,Nijhof W,Loeffler M

    更新日期:1994-12-15 00:00:00

  • Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia.

    abstract::Sixteen patients treated by allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) were evaluated by the polymerase chain reaction (PCR) for bcr/abl-specific RNA transcripts at various time points after BMT. In reconstitution experiments, one CML cell per million normal mononuclear cells c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Roth MS,Antin JH,Bingham EL,Ginsburg D

    更新日期:1989-08-01 00:00:00

  • A clinical study of the lupus anticoagulant.

    abstract::Eighty-three patients with circulating anticoagulants were studied at The New York Hospital. The lupus-type anticoagulant, an inhibitor of the prothrombin activator complex, was demonstrated in 58 patients. The inhibitor was identified using the blood and tissue thromboplastin inhibition tests. Inhibition by the lupus...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schleider MA,Nachman RL,Jaffe EA,Coleman M

    更新日期:1976-10-01 00:00:00

  • Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells.

    abstract::The transcription factor signal transducer and activator of transcription 5 (STAT5) fulfills essential roles in self-renewal in mouse and human hematopoietic stem cells (HSCs), and its persistent activation contributes to leukemic transformation, although little molecular insight into the underlying mechanisms has bee...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-08-303669

    authors: Fatrai S,Wierenga AT,Daenen SM,Vellenga E,Schuringa JJ

    更新日期:2011-03-24 00:00:00

  • The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.

    abstract::Anaplastic large cell lymphoma represents a subset of neoplasms caused by translocations that juxtapose the anaplastic lymphoma kinase (ALK) to dimerization partners. The constitutive activation of ALK fusion proteins leads to cellular transformation through a complex signaling network. To elucidate the ALK pathways s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-161018

    authors: Boccalatte FE,Voena C,Riganti C,Bosia A,D'Amico L,Riera L,Cheng M,Ruggeri B,Jensen ON,Goss VL,Lee K,Nardone J,Rush J,Polakiewicz RD,Comb MJ,Chiarle R,Inghirami G

    更新日期:2009-03-19 00:00:00

  • Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

    abstract::We conducted a double-blind, randomized multicenter trial to determine whether the addition of mycophenolate mofetil (MMF) improves the efficacy of initial systemic treatment of chronic graft-versus-host disease (GVHD). The primary endpoint was resolution of chronic GVHD and withdrawal of all systemic treatment within...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2009-02-202937

    authors: Martin PJ,Storer BE,Rowley SD,Flowers ME,Lee SJ,Carpenter PA,Wingard JR,Shaughnessy PJ,DeVetten MP,Jagasia M,Fay JW,van Besien K,Gupta V,Kitko C,Johnston LJ,Maziarz RT,Arora M,Jacobson PA,Weisdorf D

    更新日期:2009-05-21 00:00:00

  • The ring-infected erythrocyte surface antigen (RESA) of Plasmodium falciparum stabilizes spectrin tetramers and suppresses further invasion.

    abstract::The malaria parasite Plasmodium falciparum releases the ring-infected erythrocyte surface antigen (RESA) inside the red cell on entry. The protein migrates to the host cell membrane, where it binds to spectrin, but neither the nature of the interaction nor its functional consequences have previously been defined. Here...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-02-076919

    authors: Pei X,Guo X,Coppel R,Bhattacharjee S,Haldar K,Gratzer W,Mohandas N,An X

    更新日期:2007-08-01 00:00:00

  • Control of regulatory T cells is necessary for vaccine-like effects of antiviral immunotherapy by monoclonal antibodies.

    abstract::Regulatory T cells (Tregs) down-regulate immunity and are associated with chronic viral infections, suggesting that their inhibition might be used to treat life-threatening diseases. Using the FrCasE mouse retroviral model, we have recently shown that short mAb-based immunotherapies can induce life-long protective imm...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-06-432153

    authors: Nasser R,Pelegrin M,Plays M,Gros L,Piechaczyk M

    更新日期:2013-02-14 00:00:00

  • Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.

    abstract::Sickle red cell (SS RBC) adhesion is believed to contribute to the process of vaso-occlusion in sickle cell disease (SCD). We previously found that the LW RBC adhesion receptor can be activated by epinephrine to mediate SS RBC adhesion to endothelial alphavbeta3 integrin. To determine the contribution of LW activation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-11-056101

    authors: Zennadi R,Moeller BJ,Whalen EJ,Batchvarova M,Xu K,Shan S,Delahunty M,Dewhirst MW,Telen MJ

    更新日期:2007-10-01 00:00:00

  • The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs.

    abstract::A competitive repopulation assay in the dog was used to develop improved gene transfer protocols for hematopoietic stem cell gene therapy. Using this assay, we previously showed improved gene transfer into canine hematopoietic repopulating cells when CD34-enriched marrow cells were cocultivated on gibbon ape leukemia ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Goerner M,Bruno B,McSweeney PA,Buron G,Storb R,Kiem HP

    更新日期:1999-10-01 00:00:00

  • Residual amounts of glycoproteins IIb and IIIa may be present in the platelets of most patients with Glanzmann's thrombasthenia.

    abstract::Glanzmann's thrombasthenia is an inherited bleeding disorder characterized by abnormalities of platelet membrane glycoproteins (GP) IIb and IIIa. Most patients, usually designated as type I, have been reported to have undetectable levels of GP IIb and GP IIIa with the assay used. We have used polyclonal rabbit antibod...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nurden AT,Didry D,Kieffer N,McEver RP

    更新日期:1985-04-01 00:00:00

  • Erythropoietin receptor haploinsufficiency and in vivo interplay with granulocyte-macrophage colony-stimulating factor and interleukin 3.

    abstract::Erythropoietin (EPO) and its receptor (EPOR) are critical for definitive erythropoiesis, as mice lacking either gene product die during embryogenesis with severe anemia. Here we demonstrate that mice expressing just one functional allele of the EpoR have lower hematocrits and die more frequently than do wild-type litt...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.7.2603

    authors: Jegalian AG,Acurio A,Dranoff G,Wu H

    更新日期:2002-04-01 00:00:00

  • Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1.

    abstract::We analyzed the expression of myelomonocytic-associated antigens on lymphocytes from B cell chronic lymphocytic leukemia (B-CLL) patients. Blood mononuclear cells were depleted of monocytes by one-step Percoll density gradient centrifugation and tested for antigen expression by fluorescent microscopy and flow cytometr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morabito F,Prasthofer EF,Dunlap NE,Grossi CE,Tilden AB

    更新日期:1987-12-01 00:00:00

  • Myeloma bone disease and proteasome inhibition therapies.

    abstract::Bone disease is one of the most debilitating manifestations of multiple myeloma. A complex interdependence exists between myeloma bone disease and tumor growth, creating a vicious circle of extensive bone destruction and myeloma progression. Proteasome inhibitors have recently been shown to promote bone formation in v...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2007-03-067710

    authors: Terpos E,Sezer O,Croucher P,Dimopoulos MA

    更新日期:2007-08-15 00:00:00

  • Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody.

    abstract::Protein vaccines for T-cell immunity are not being prioritized because of poor immunogenicity. To overcome this hurdle, proteins are being targeted to maturing dendritic cells (DCs) within monoclonal antibodies (mAbs) to DC receptors. To extend the concept to humans, we immunized human immunoglobulin-expressing mice w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-06-288068

    authors: Cheong C,Choi JH,Vitale L,He LZ,Trumpfheller C,Bozzacco L,Do Y,Nchinda G,Park SH,Dandamudi DB,Shrestha E,Pack M,Lee HW,Keler T,Steinman RM,Park CG

    更新日期:2010-11-11 00:00:00

  • Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia.

    abstract::The von Willebrand receptor complex, which is composed of the glycoproteins Ibα, Ibβ, GPV, and GPIX, plays an essential role in the earliest steps in hemostasis. During the last 4 decades, it has become apparent that loss of function of any 1 of 3 of the genes encoding these glycoproteins (namely, GP1BA, GP1BB, and GP...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-08-732248

    authors: Sivapalaratnam S,Westbury SK,Stephens JC,Greene D,Downes K,Kelly AM,Lentaigne C,Astle WJ,Huizinga EG,Nurden P,Papadia S,Peerlinck K,Penkett CJ,Perry DJ,Roughley C,Simeoni I,Stirrups K,Hart DP,Tait RC,Mumford AD,NI

    更新日期:2017-01-26 00:00:00

  • Human signaling protein 14-3-3zeta interacts with platelet glycoprotein Ib subunits Ibalpha and Ibbeta.

    abstract::The initiation of primary hemostasis is mediated by interaction of the platelet glycoprotein Ib (GPIb) surface receptor and its arterial subendothelial von Willebrand factor (vWF) ligand. The intracellular signaling immediately following GPIb receptor occupancy connecting the adhesive event to platelet activation and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Calverley DC,Kavanagh TJ,Roth GJ

    更新日期:1998-02-15 00:00:00

  • Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors.

    abstract::The mechanisms by which transforming growth factor beta (TGF-beta) exerts a negative effect on cell-cycle entry in primary human hematopoietic stem/progenitor cells were examined at the molecular and cellular levels. After treatment of primary human CD34+ progenitors with TGF-beta there was a decrease in the levels of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.2.499

    authors: Dao MA,Hwa J,Nolta JA

    更新日期:2002-01-15 00:00:00

  • Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI.

    abstract::Graft-versus-host disease (GVHD) is a prominent barrier to allogeneic hematopoietic stem cell transplantation (AHSCT). Definitive diagnosis of GVHD is invasive, and biopsies of involved tissues pose a high risk of bleeding and infection. T cells are central to GVHD pathogenesis, and our previous studies in a chronic G...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005770

    authors: Assmann JC,Farthing DE,Saito K,Maglakelidze N,Oliver B,Warrick KA,Sourbier C,Ricketts CJ,Meyer TJ,Pavletic SZ,Linehan WM,Krishna MC,Gress RE,Buxbaum NP

    更新日期:2021-01-07 00:00:00

  • Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

    abstract::The introduction of imatinib mesylate (IM) has revolutionized the treatment of chronic myeloid leukemia (CML). Although experience is too limited to permit evidence-based evaluation of survival, the available data fully justify critical reassessment of CML management. The panel therefore reviewed treatment of CML sinc...

    journal_title:Blood

    pub_type: 杂志文章,实务指引,评审

    doi:10.1182/blood-2006-02-005686

    authors: Baccarani M,Saglio G,Goldman J,Hochhaus A,Simonsson B,Appelbaum F,Apperley J,Cervantes F,Cortes J,Deininger M,Gratwohl A,Guilhot F,Horowitz M,Hughes T,Kantarjian H,Larson R,Niederwieser D,Silver R,Hehlmann R,Europea

    更新日期:2006-09-15 00:00:00

  • Alloantigenic composition of the endothelial vitronectin receptor.

    abstract::Endothelial cells synthesize a heterodimeric adhesion molecule, the vitronectin receptor (VnR), which is similar to the platelet glycoprotein (GP)IIb/IIIa complex. The subunits of the endothelial VnR (VnR alpha and GPIIIa) have been studied for their ability to express alloantigens associated with platelet GPIIb and I...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Giltay JC,Leeksma OC,von dem Borne AE,van Mourik JA

    更新日期:1988-07-01 00:00:00

  • Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F.

    abstract::Phosphatidylserine (PS) is normally confined to the cytoplasmic leaflet of the red blood cell (RBC) membrane, but some sickle RBCs expose PS in the outer leaflet (PS+ cells). This study examined the relationships among PS externalization, fetal hemoglobin content, hydration state, and cell age. Sickle RBCs exhibit a w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-11-3416

    authors: Yasin Z,Witting S,Palascak MB,Joiner CH,Rucknagel DL,Franco RS

    更新日期:2003-07-01 00:00:00

  • Role of stromal cells and macrophages in fibronectin biosynthesis and matrix assembly in human long-term marrow cultures.

    abstract::Fibronectin is a major component of the extracellular matrix of adherent layers of human long-term marrow cultures where it may stabilize the extracellular matrix network and provide adhesion sites for primitive hemopoietic cells. This study was devised to analyze the role of adherent cell populations in fibronectin s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lerat H,Lissitzky JC,Singer JW,Keating A,Herve P,Charbord P

    更新日期:1993-09-01 00:00:00

  • Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis.

    abstract::Accumulating evidence has designated B cells as central players in the pathogenesis of immune diseases. In the late 1990s, anti-CD20 monoclonal antibodies were developed for the treatment of B-cell non-Hodgkin lymphomas, offering the opportunity to efficiently deplete the B-cell compartment for therapeutic immunointer...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2010-01-266668

    authors: Thaunat O,Morelon E,Defrance T

    更新日期:2010-07-29 00:00:00

  • Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation.

    abstract::Activation of plasminogen, the zymogen of the primary thrombolytic enzyme, plasmin, is markedly promoted when plasminogen is bound to cell surfaces, arming cells with the broad spectrum proteolytic activity of plasmin. In addition to its role in thrombolysis, cell surface plasmin facilitates a wide array of physiologi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-11-188938

    authors: Andronicos NM,Chen EI,Baik N,Bai H,Parmer CM,Kiosses WB,Kamps MP,Yates JR 3rd,Parmer RJ,Miles LA

    更新日期:2010-02-18 00:00:00